by Graciela Gutierrez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainYou have your mother's eyes and your father's smile, but genetics is much more than just what's on th
by Graciela Gutierrez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainYou have your mother's eyes and your father's smile, but genetics is much more than just what's on th
by Stephan Wiegand,Dresden University of TechnologyDesign of ZFDs for the loxF8 genomic locus. a, Genomic sequences flanking loxF8. Binding sites of the designed ZFDs upstream (orange, ZFL1–2) a
by Stephan Wiegand,Dresden University of TechnologyDesign of ZFDs for the loxF8 genomic locus. a, Genomic sequences flanking loxF8. Binding sites of the designed ZFDs upstream (orange, ZFL1–2) a
by Dennis ThompsonThe Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protectio
by Dennis ThompsonThe Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protectio
by Menzies School of Health ResearchCumulative incidence of first antibiotic prescription by age in months. Credit: Menzies School of Health ResearchA study of antibiotic prescription rates for Aborig
by Menzies School of Health ResearchCumulative incidence of first antibiotic prescription by age in months. Credit: Menzies School of Health ResearchA study of antibiotic prescription rates for Aborig
byJohns Hopkins University School of MedicineNeuronal membrane proteasomes are labeled with a red compound and appear in a subset of sensory neurons that are labeled with green compound. Note, n
byJohns Hopkins University School of MedicineNeuronal membrane proteasomes are labeled with a red compound and appear in a subset of sensory neurons that are labeled with green compound. Note, n
byUniversity of SaskatchewanHepG2/C3A cells express NUCB1/NLP and NUCB2/NESF-1. Credit:Communications Biology(2024). DOI: 10.1038/s42003-024-06314-2University of Saskatchewan (USask)
byUniversity of SaskatchewanHepG2/C3A cells express NUCB1/NLP and NUCB2/NESF-1. Credit:Communications Biology(2024). DOI: 10.1038/s42003-024-06314-2University of Saskatchewan (USask)
by American Society of Tropical Medicine & HygieneCredit: CC0 Public DomainClimate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden,
by American Society of Tropical Medicine & HygieneCredit: CC0 Public DomainClimate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden,
by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
by Impact Journals LLCExperimental design for the results shown in Figures 3 and 4. Credit: 2023 Copp et al.A newresearch papertitled "Sirtuin 6 activation rescues the age-related dec
by Impact Journals LLCExperimental design for the results shown in Figures 3 and 4. Credit: 2023 Copp et al.A newresearch papertitled "Sirtuin 6 activation rescues the age-related dec
byVanderbilt University Medical CenterZn-deficient mice produce higher levels of IL-13. Credit:Nature Microbiology(2024). DOI: 10.1038/s41564-024-01849-wDietary zinc deficiency promo
byVanderbilt University Medical CenterZn-deficient mice produce higher levels of IL-13. Credit:Nature Microbiology(2024). DOI: 10.1038/s41564-024-01849-wDietary zinc deficiency promo
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended prog
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended prog